More patients in the zoledronic acid group had renal toxic effects than in the ibandronic acid group ( 226 [ 32 % ] of 697 vs 172 [ 24 % ] of 704 ) but rates of osteonecrosis of the jaw were low in both groups ( nine [ 1 % ] of 697 vs five [ < 1 % ] of 704 ) .